全文获取类型
收费全文 | 2355247篇 |
免费 | 191575篇 |
国内免费 | 29228篇 |
专业分类
耳鼻咽喉 | 27328篇 |
儿科学 | 73542篇 |
妇产科学 | 57025篇 |
基础医学 | 305593篇 |
口腔科学 | 60619篇 |
临床医学 | 231097篇 |
内科学 | 380569篇 |
皮肤病学 | 49534篇 |
神经病学 | 202145篇 |
特种医学 | 105632篇 |
外国民族医学 | 309篇 |
外科学 | 341423篇 |
综合类 | 115249篇 |
现状与发展 | 242篇 |
一般理论 | 1075篇 |
预防医学 | 188854篇 |
眼科学 | 45285篇 |
药学 | 188093篇 |
425篇 | |
中国医学 | 41024篇 |
肿瘤学 | 160987篇 |
出版年
2023年 | 57660篇 |
2022年 | 85870篇 |
2021年 | 113464篇 |
2020年 | 105236篇 |
2019年 | 86958篇 |
2018年 | 122912篇 |
2017年 | 110568篇 |
2016年 | 106710篇 |
2015年 | 110579篇 |
2014年 | 199919篇 |
2013年 | 229016篇 |
2012年 | 122638篇 |
2011年 | 108860篇 |
2010年 | 141154篇 |
2009年 | 118504篇 |
2008年 | 67335篇 |
2007年 | 68573篇 |
2006年 | 57131篇 |
2005年 | 51047篇 |
2004年 | 43571篇 |
2003年 | 37972篇 |
2002年 | 31800篇 |
2001年 | 32039篇 |
2000年 | 25910篇 |
1999年 | 25361篇 |
1998年 | 21811篇 |
1997年 | 18998篇 |
1996年 | 20943篇 |
1995年 | 19173篇 |
1994年 | 16534篇 |
1993年 | 14837篇 |
1992年 | 11943篇 |
1991年 | 10835篇 |
1990年 | 10765篇 |
1989年 | 10322篇 |
1988年 | 10917篇 |
1987年 | 10709篇 |
1986年 | 9993篇 |
1985年 | 11644篇 |
1984年 | 11622篇 |
1983年 | 8850篇 |
1982年 | 9424篇 |
1981年 | 8426篇 |
1980年 | 7565篇 |
1979年 | 7091篇 |
1978年 | 6124篇 |
1977年 | 5062篇 |
1976年 | 4609篇 |
1975年 | 4003篇 |
1974年 | 3580篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
102.
《Cancer cell》2022,40(3):318-334.e9
- Download : Download high-res image (268KB)
- Download : Download full-size image
103.
104.
105.
《European journal of surgical oncology》2022,48(3):621-631
ObjectivesThe aim of this meta-analysis was to conduct a contemporary systematic review of high quality non-randomised controlled trials to determine the effect of pre-liver transplantation (LT) transarterial chemoembolisation (TACE) on long-term survival and complications of hepatocellular carcinoma (HCC) patients.BackgroundTACE is used as a neoadjuvant therapy to mitigate waitlist drop-out for patients with HCC awaiting LT. Previous studies have conflicting conclusions on the effect of TACE on long-term survival and complications of HCC patients undergoing LT.MethodsCINAHL, Cochrane Controlled Register of Trials, Embase, PubMed, and Web of Science were systematically searched. Baseline characteristics included number of patients outside Milan criteria, tumour diameter, MELD score, and time on the waiting list. Primary outcomes included 3- and 5-year overall and disease-free survival. Secondary outcomes included tumour recurrence, 30-day postoperative mortality, and hepatic artery and biliary complications.ResultsTwenty-one high-quality NRCTs representing 8242 patients were included. Tumour diameter was significantly larger in TACE patients (3.49 cm vs 3.15 cm, P = 0.02) and time on the waiting list was significantly longer in TACE patients (4.87 months vs 3.46 months, P = 0.05), while MELD score was significantly higher in non-TACE patients (10.81 vs 12.35, P = 0.005). All primary and secondary outcomes displayed non-significant differences.ConclusionPatients treated with TACE had similar survival and postoperative outcomes to non-TACE patients, however, they had worse prognostic features compared to non-TACE patients. These findings strongly support the current US and European clinical practice guidelines that neoadjuvant TACE can be used for patients with longer expected waiting list times (specifically >6 months). Randomised controlled trials would be needed to increase the quality of evidence. 相似文献
106.
《European journal of surgical oncology》2022,48(9):2061-2067
BackgroundThis study compares morbidity and mortality associated with retroperitoneal and transperitoneal para-aortic lymphadenectomy (PAAL) for pretherapeutic nodal staging of locally advanced cervical cancers (FIGO IB3–IVA).MethodsPre-, per- and postoperative data of patients treated for locally advanced stage cervical cancer between 1999 and 2018 in 12 French referral centers (FRANCOGYN Study Group) were retrospectively collected.ResultsThe study was conducted using a sample of 448 patients, of whom 223 (49,8%) underwent retroperitoneal (group 1) and 225 (50,2%) had transperitoneal PAAL (group 2). No differences were noted concerning clinical and histological characteristics between the two groups. Among these 448 patients, 23 (5,1%) had an intraoperative complication (9 (2,0%) in group 1 and 14 (3,1%) in group 2, p = 0.28) and 47 (10,5%) had a postoperative complication (22 (4,9%) in group 1 and 25 (5,6%) in group 2, p = 0.44), only one of which required revision surgery but the patient died. The length of hospital stay was significantly shorter in group 1 than in group 2 (3.97 versus 4.88 days, p < 0.001). There was no significant difference in mortality between the two groups; 34 of 223 patients in group 1 (15.3%) and 40 of 225 patients in group 2 (15.6%) died (HR = 0.968, 95% CI [0.591–1.585]). There was no significant difference in recurrence-free or overall survival between the two groups.ConclusionRetroperitoneal PAAL appears as a valuable and safety surgical route for nodal staging in locally advanced cervical cancer compared with standard transperitoneal PAAL. 相似文献
107.
BackgroundLeft ventricular unloading with Impella may improve survival outcomes in patients with acute myocardial infarction complicated by cardiogenic shock (AMI-CS). However, the optimal timing to initiate left ventricular unloading has yet to be established. Therefore, we conducted a systematic review and meta-analysis to compare survival in patients with AMI-CS who were supported with Impella prior to PCI (pre-PCI) to those in whom support was initiated following PCI (post-PCI).MethodsAll studies that evaluated the impact of pre-PCI versus post-PCI Impella placement in patients with AMI-CS were included. Primary endpoints included in-hospital, 30-day, and 6-month survival rates.ResultsWe identified five observational studies comparing outcomes in 432 patients with AMI-CS, of which 173 patients were treated with Impella pre-PCI and 259 patients post-PCI. Patients in the pre-PCI group had lower in-hospital mortality compared to patients in the post-PCI group (RR 0.62, 95% CI: 0.50–0.76, I2 = 0%). The lower mortality rate in the pre-PCI group remained evident at 30 days (HR 0.60, 95% CI: 0.47–0.78, I2 = 0%) and at 6 months (HR 0.66, 95% CI: 0.44–0.97, I2 = 0%). There was no difference in the risk of adverse events including reinfarction, stroke, major bleeding, acute ischemic limb, access site bleeding, and hemolysis.ConclusionsIn this meta-analysis of studies evaluating survival among AMI-CS patients with left ventricular unloading initiated pre- versus post-PCI, Impella placement prior to PCI was associated with improved survival. 相似文献
108.
109.
《HPB : the official journal of the International Hepato Pancreato Biliary Association》2022,24(8):1252-1260
BackgroundThe clinical importance of postoperative hyperamylasemia (POHA) grade is unknown. Our objectives were to evaluate the association of POHA grade with clinically relevant postoperative pancreatic fistula (CR-POPF) and compare its prognostic utility against postoperative day 1 drain fluid amylase (DFA-1).MethodsPatients who underwent pancreatectomy from January 2019 through March 2020 were identified in the ACS NSQIP pancreatectomy-targeted dataset. POHA grade was assigned using post-operative serum amylase and clinical sequelae. The primary outcome was CR-POPF within 30 days. The association of POHA grade with CR-POPF was assessed using multivariable logistic regression, and c-statistics were used to compare POHA grade versus DFA-1.ResultsPOHA occurred in 520 patients at 98 hospitals, including 261 (50.2%) with grade A, 234 (45.0%) with grade B, and 25 (4.8%) with grade C POHA. CR-POPFs were increased among patients with grade B (66.2%, OR 9.28 [5.84–14.73]) and C (68.0%, OR 10.50 [3.77–29.26]) versus grade A POHA (19.2%). POHA-inclusive models better predicted CR-POPF than those with DFA-1 alone (p < 0.002) and models with both predictors outperformed POHA alone (p = 0.039).ConclusionPOHA grade represents a measure of post-pancreatectomy outcomes that predicts CR-POPF and outperforms DFA-1 but must be aligned with new international definitions. 相似文献
110.